tiprankstipranks
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market
ATXI
Avenue Therapeutics
RESEARCH TOOLSreports
Want to see ATXI full AI Analyst Report?

Avenue Therapeutics (ATXI) Income Statement

331 Followers

Avenue Therapeutics Income Statement

Last quarter (Q4 2025), Avenue Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Avenue Therapeutics's net income was $-709.00K. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.69M$ 11.28M$ 14.54M$ 8.04M$ 3.74M
Depreciation and Amortization
$ 0.00$ 0.00$ 14.54M$ 0.00$ 3.74M
EBITDA
$ -3.29M$ -11.70M$ 4.05M$ -2.44M$ 7.00K
Operating Income
$ -3.29M$ -11.28M$ -14.54M$ -8.04M$ -3.74M
Other Income/Expenses
$ 339.00K$ -413.00K$ 4.05M$ 4.44M$ 7.00K
Pretax Income
$ -2.95M$ -11.70M$ -10.49M$ -3.60M$ -3.73M
Net Income
$ -2.91M$ -11.65M$ -10.38M$ -3.55M$ -3.73M
Per Share Metrics
Basic EPS
$ -0.93$ -0.90$ -73.60$ -121.91$ -3.29
Diluted EPS
$ -0.93$ -0.90$ -73.48$ -121.91$ -3.29
Weighted Average Shares Outstanding
 3.13M 12.95M 141.00K 29.14K 1.13M
Weighted Average Shares Outstanding (Diluted)
 3.13M 12.95M 141.22K 29.14K 1.13M
Currency in USD

Avenue Therapeutics Earnings and Revenue History